CFVLX | VIVAX | CFVLX / VIVAX | |
Total Expense Ratio | 0.71 | 0.17 | 418% |
Annual Report Gross Expense Ratio | 0.71 | 0.17 | 418% |
Fund Existence | 28 years | 33 years | - |
Gain YTD | 7.174 | 6.724 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 257M | 195B | 0% |
Annual Yield % from dividends | 2.23 | 2.06 | 108% |
Returns for 1 year | 4.93 | 9.76 | 51% |
Returns for 3 years | 10.27 | 34.31 | 30% |
Returns for 5 years | 39.81 | 74.87 | 53% |
Returns for 10 years | 35.82 | 116.32 | 31% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WFDRX | 32.68 | 0.49 | +1.52% |
Allspring SMID Cap Growth Fund - Cl R6 | |||
ZVGIX | 59.38 | 0.67 | +1.14% |
Zevenbergen Genea Institutional | |||
TADGX | 83.68 | 0.38 | +0.46% |
T. Rowe Price Dividend Growth Advisor | |||
GSIKX | 21.17 | N/A | N/A |
Goldman Sachs International Eq Inc Instl | |||
ARTLX | 15.57 | -0.01 | -0.06% |
Artisan Value Investor |